Although there were some negatives, there were plenty of Positives that I really love. You know you've spent too much time focusing on the negatives when you get a TU from Hopeful2...thanks mate. And you know that perhaps you have laboured the points when you get another TU from Hopeful2.
So let's take a look at some of the positives and there are 14 that I counted. Thanks for your posts Skypilot & Born2Reign.
Current available Products: Magnetic Power Booster (Wave 2) in several Asian countries, continue 18+ Magnemasks started Sep - fastest growing, largest volume product to date. Continue 18+ and Nth America Variant to Magnemasks launching in NY
18+ countries for both products and additional variants, indicates that we should see a couple of Quarterlies on the way with better revenues.
Personalisation: 2nd tech licence - Master Licencing Agreement - aim to get done before AGM, but dependent on P&G They must give us luanch plans with intentions next 18 months And must have products on shelves within 30 months, or we have right to terminate Provisions in there that alow us to move forward Will take a full year to get product out 1000 person trial (considerable) Very exciting for company.
Prior to AGM should cement Personalisation as an additional and future income stream.
BodyGuard: Pre-production have now been manufactured by manufacturing partner. Ready to distribute to those interested in BG chemistry, and delivery chemistry Whole move to BG is going very well, prototypes are advanced and companies are readying consumer programs Targeting 2018 for the year BG gets commercialised, either by ourselves or commercial partners Hold great hopes for it in the future Most likely with first BG product. Partner waiting for off-tool product to come off production line One in USA, UK, Japan and Europe Now keen on looking at models that are close to final product 2 of them want to use their own chemistry in the products... good because it provides wider use of BG BG is extremely complex that's why we enlisted a manufacturer... who has done a great job bringing to final form BG most likely after P&G, but not the only BG targeting particular parties at this stage
Progress. Promising commercialisation target for 2018.
Surface Hygiene: Two major multinational interested. 500% improvement. Bathroom Mold, hydrogel & microarray Enhanced surface pentration Enhance anticeptic efficienicy Enhance interface betwen chemistry and cell walls Has excellent growth potential Surface hygine - going through validation programs Very hopeful of getting linked in to at least one commercial arrangement with at least one product launched 18/19 Progress is going extremely well Great deal of enthusiasm
Progress.
Ibuprofen: Uni is now testing Ibroprofen Ibuprofen potential is huge - many companies use this chemistry as part of their product range Broadening the results of Curtin to those companies Don't want to mention companies without their approval Provide a topical delivery route at least equal to the ones out there today Quite attractive for many manufacturers around the world Timing wise - underway... takes about 3 months to do all test, and another month to prepare results So should be ready early next year Unable to discuss too much due to not having permission from Pfizer. Ibuprofen potential is huge and the ability to treat pain locally is very attractive proposition for many companies as Ibuprofen is a widely used drug/painkiller.
Progress.
Oral Healthcare: Recently oral tech has been picked up by Oral B range group... progressing extremely well
Data from concept to proofs going well
Strong level of interest from them
No technical objections so far
Very hopeful to move oral healthcare forward with P&G
Progress.
Patents: Patents are increasing in number.
Progress.
Royalty Rate: 2 - 3%
Progress. Disclosure. Transparency.
MicroNeedles: Have taken a device we've designed and built with micro-needle application, and present to company looking for hot/cold patch... and in fact the chassis of micro needle device proved to be ideal
Whilst not working in this space, it's being replaced in a brand new space
New.
Accelerators: Accelerator - we met with one in SG last week... closely aligned with P&G. Terrific opportunity we will have a formal arrangement with that accelerator... not BG but another product
Another accelerator based in Chicago, interested in BG.. want to do consumer testing themselves. Haven't reached any commercial discussion with them. SG is more advanced.
Progress.
COTY: Change to Coty's business resulted in substantial shift in management and R&D
Putting cap on internal new products
However, they have re-engaged, met with them and their senior new R&D smarts, and they're coming to speed with our products and clinical results... working towards bringing that to a head... Have a meeting with Coty next week to bring it forward
The agreement that's being negotiated with P&G has a carve out re Coty.
The exclusive agreement on microarray technology with P&G is not applicable to Coty (I could have misheard this part, but from what I understood - any OBJ programs with the P&G brands that were sold to Coty are still in play and not limited by our exclusive microarray technology agreement with P&G).
born2reign comment: If I heard and understand correctly, this is a huge deal. If OBJ/Coty/P&G have gone through the legal effort to allow these new Coty brands to pursue any microarray workplans, then my guess is we have more than one workplan ongoing with one of these brands that Coty have picked up.
Back in business. Progress.
Advanced Packaging: What we were looking for and achieve, was how do we incorporate OBJ's formulations in high quality packaged products... without increasing R&D costs
2 products taken up by P&G
We're told by P&G it will be launched 17/18... well on track. Separate product like other 3 products. Co-packaged like other 3
similar pathway like other products
There are very advanced plans for a very integrated product during that timeframe
This one really intrigues me. Has P&G taken this up for the upcoming launch in the next year for the SK-II & Olay Magnetic Eye Wand as an Advanced Packaged Integrated Product or is it the newer version of Magnemasks to be launched in North America or will it be part of the newer CellScience Range? Hmmmm. Success anyway you look at it.
Haircare: Our own distributon of skin and hair products to go down value chain.. so we're not dependent on 3rd parties Set up for growth in the company
New. Progress.
Ultrasound: New ultrasound tech we've created over last 6 months.. was in position to present to potential partners.. and they really liked what they say
New. Progress.
Overall, there is alot to be thankful for. Although not perfect, we now have some much needed transparency on most topics, which is what we have all been asking for. Our share-price may languish temporarily, but it is pretty obvious to see where we are headed over the medium to long-term. The BOD should be commended for taking this first step in providing much clearer and concise communications to their Shareholders. Hopefully the first of many to come and places the BOD in a much more amicable position for the upcoming AGM. Well done BOD and Thankyou.
(20min delay)